These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 30921475)
1. Circulating CD137 Nong J; Wang J; Gao X; Zhang Q; Yang B; Yan Z; Wang X; Yi L; Wang Q; Gao Y; Hu A; Qin N; Wei P; Zhang H; Zhang S Scand J Immunol; 2019 Jun; 89(6):e12765. PubMed ID: 30921475 [TBL] [Abstract][Full Text] [Related]
2. Human CD8 Machicote A; Belén S; Baz P; Billordo LA; Fainboim L Front Immunol; 2018; 9():2788. PubMed ID: 30555473 [TBL] [Abstract][Full Text] [Related]
3. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy. Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008 [TBL] [Abstract][Full Text] [Related]
4. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592 [TBL] [Abstract][Full Text] [Related]
5. Association of peripheral NK cell counts with Helios Trojan K; Zhu L; Aly M; Weimer R; Bulut N; Morath C; Opelz G; Daniel V Clin Exp Immunol; 2017 Jun; 188(3):467-479. PubMed ID: 28194759 [TBL] [Abstract][Full Text] [Related]
6. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer]. Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005 [TBL] [Abstract][Full Text] [Related]
7. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419 [TBL] [Abstract][Full Text] [Related]
8. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression]. Chen YL; Chen XR; Qin LX; Yang YF; Tang YM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412 [TBL] [Abstract][Full Text] [Related]
9. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients. Kao JK; Hsue YT; Lin CY J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602 [TBL] [Abstract][Full Text] [Related]
10. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Erfani N; Mehrabadi SM; Ghayumi MA; Haghshenas MR; Mojtahedi Z; Ghaderi A; Amani D Lung Cancer; 2012 Aug; 77(2):306-11. PubMed ID: 22608141 [TBL] [Abstract][Full Text] [Related]
11. Subset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV Infection. Nikolova M; Wiedemann A; Muhtarova M; Achkova D; Lacabaratz C; Lévy Y PLoS Pathog; 2016 Nov; 12(11):e1005995. PubMed ID: 27829019 [TBL] [Abstract][Full Text] [Related]
12. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck. Chikamatsu K; Sakakura K; Whiteside TL; Furuya N Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408 [TBL] [Abstract][Full Text] [Related]
14. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy. Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739 [TBL] [Abstract][Full Text] [Related]
15. Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis. Luu K; Patwardhan MV; Zeng Q; Wickström SL; Lundqvist A; Schwarz H Cells; 2021 Feb; 10(2):. PubMed ID: 33572150 [TBL] [Abstract][Full Text] [Related]
16. Altered levels of circulating CD8 Zhai X; Wang Y; Guo H; Liang Z; Feng M; Wu Y; Qin Y; Zhao X; Gao C; Luo J Clin Rheumatol; 2022 Jun; 41(6):1697-1708. PubMed ID: 35171365 [TBL] [Abstract][Full Text] [Related]
17. Blood immune cell biomarkers in lung cancer. Riemann D; Cwikowski M; Turzer S; Giese T; Grallert M; Schütte W; Seliger B Clin Exp Immunol; 2019 Feb; 195(2):179-189. PubMed ID: 30246868 [TBL] [Abstract][Full Text] [Related]
18. CD137 Agonist Therapy Can Reprogram Regulatory T Cells into Cytotoxic CD4+ T Cells with Antitumor Activity. Akhmetzyanova I; Zelinskyy G; Littwitz-Salomon E; Malyshkina A; Dietze KK; Streeck H; Brandau S; Dittmer U J Immunol; 2016 Jan; 196(1):484-92. PubMed ID: 26608920 [TBL] [Abstract][Full Text] [Related]
19. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery. Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703 [TBL] [Abstract][Full Text] [Related]
20. Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire. Battaglia A; Ferrandina G; Buzzonetti A; Malinconico P; Legge F; Salutari V; Scambia G; Fattorossi A Immunology; 2003 Nov; 110(3):304-12. PubMed ID: 14632657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]